Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL825761 | 0.94 | PKM (0.37) | PKMNPSR1RXFP1ALDH1A1 | |
| SCHEMBL19097324 | 0.91 | PKM (0.35) | PKMNPSR1RXFP1ALDH1A1 | |
| SCHEMBL12275600 | 0.86 | PKM (0.33) | PKMNPSR1RXFP1ALDH1A1 | |
| SCHEMBL12276071 | 0.83 | PKM (0.32) | PKMNPSR1RXFP1ALDH1A1 | |
| SCHEMBL15281070 | 0.83 | PKM (0.32) | PKMNPSR1RXFP1ALDH1A1 | |
| SCHEMBL14441072 | 0.83 | PKM (0.32) | PKMNPSR1RXFP1ALDH1A1 | |
| SCHEMBL12892777 | 0.82 | PKM (0.39) | PKMNPSR1RXFP1ALDH1A1 | |
| SCHEMBL21235819 | 0.82 | PKM (0.34) | PKMNPSR1RXFP1ALDH1A1 | |
| SCHEMBL21235818 | 0.82 | PKM (0.34) | PKMNPSR1RXFP1ALDH1A1 | |
| SCHEMBL18716721 | 0.81 | PKM (0.31) | PKMNPSR1RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200152395-A1 | LAYERED HYBRID ORGANIC-INORGANIC PEROVSKITE MATERIALS | UNIVERSITEIT HASSELT (BE) | 2020-05-14 | — | — | US | disclosed |
| EP-2588527-B1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL IND LTD (JP) | 2017-10-25 | — | — | EP | disclosed |
| US-20170186953-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170186953-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-8815639-B2 | Hole transport compositions and related devices and methods (II) | SOLVAY USA, INC. (US) | 2014-08-26 | — | — | US | disclosed |
| US-8815639-B2 | Hole transport compositions and related devices and methods (II) | SOLVAY USA, INC. (US) | 2014-08-26 | — | — | US | disclosed |
| US-8535974-B2 | Hole transport compositions and related devices and methods (II) | PLEXTRONICS, INC. (US) | 2013-09-17 | — | — | US | disclosed |
| US-8535974-B2 | Hole transport compositions and related devices and methods (II) | PLEXTRONICS, INC. (US) | 2013-09-17 | — | — | US | disclosed |
| US-20120003790-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AMD METHODS (II) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120003790-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AMD METHODS (II) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| WO-2012003485-A2 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | PLEXTRONICS, INC. (US) | 2012-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200152395-A1 | LAYERED HYBRID ORGANIC-INORGANIC PEROVSKITE MATERIALS | NCL, KCNN4, SLC9A3 | PKM 3266/4885NPSR1 3017/4885RXFP1 3699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.